| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $43.6M | — | -2.4% |
| Cost of Revenue | $2.2M | — | -1.7% |
| R&D Expense | $8.7M | — | +9.1% |
| SG&A Expense | $19.1M | — | -2.0% |
| Operating Income | $199K | — | -92.5% |
| Pre-tax Income | $1.7M | — | -31.0% |
| Income Tax | $32K | — | +255.6% |
| Net Income | $1.2M | — | -28.9% |
| EPS (Basic) | $0.01 | — | -50.0% |
| EPS (Diluted) | $0.01 | — | -50.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $45.5M | -27.1% | — |
| Short-term Investments | $11.5M | — | — |
| Accounts Receivable | $16.9M | +15.3% | +57.9% |
| Current Assets | $80.5M | -5.2% | +11.8% |
| Total Assets | $186.4M | -2.2% | +1.4% |
| Current Liabilities | $30.0M | -17.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.3M | — | -122.8% |
| Investing Cash Flow | -$13.0M | — | -256.8% |
| Financing Cash Flow | -$2.6M | — | -264.5% |
| -6.7% |
| Total Liabilities | $51.6M | -12.4% | -14.2% |
| Stockholders' Equity | $59.7M | +4.4% | +23.2% |